The announcement of a class action lawsuit against Elanco Animal Health is likely to negatively impact its stock price in the short term as it raises concerns about potential financial liabilities and investor sentiment. The notification to shareholders and the mention of a deadline for potential recovery under federal securities laws further emphasize the seriousness of the situation.